SCHEMBL3282899

SCHEMBL3282899

Cc1cccc(C(Cc2cc(F)ccc2F)NC(=O)NCCF)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.40
SLC6A5 Q9Y345 1/20 0.40
OPRM1 P35372 3/20 0.37
PGR P06401 1/20 0.37
AR P10275 1/20 0.37
OPRL1 P41146 3/20 0.37
CCR3 P51677 1/20 0.37
CTSA P10619 2/20 0.37
CTSB P07858 2/20 0.37
DPP4 P27487 3/20 0.36
DPP9 Q86TI2 1/20 0.35
MDM2 Q00987 1/20 0.35
CYP26A1 O43174 1/20 0.35
KMT2A Q03164 1/20 0.34
CTSL P07711 1/20 0.34
CTSS P25774 1/20 0.34
CTSK P43235 1/20 0.34
EPHX2 P34913 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3281456 0.89 KMT2A (0.42) SLC6A9SLC6A5OPRM1CCR3CTSA
SCHEMBL3287645 0.86 CTSA (0.39) SLC6A9SLC6A5OPRM1OPRL1CCR3
SCHEMBL3281878 0.86 CCR3 (0.46) SLC6A9SLC6A5OPRM1OPRL1CCR3
SCHEMBL3285359 0.85 CCR3 (0.46) SLC6A9SLC6A5OPRM1OPRL1CCR3
SCHEMBL3282246 0.82 POLB (0.41) CCR3DPP4DPP9EPHX2
SCHEMBL3281208 0.81 CCR3 (0.57) CCR3CTSBKMT2ACTSLCTSS
SCHEMBL3286069 0.78 CCR3 (0.46) CCR3KMT2ACTSLCTSSEPHX2
SCHEMBL3282681 0.77 CCR3 (0.42) SLC6A9SLC6A5OPRM1CCR3CTSB
SCHEMBL3282182 0.77 ALDH1A1 (0.40) CCR3CYP26A1KMT2A
SCHEMBL3282680 0.77 CNR1 (0.47) CCR3CTSBKMT2ACTSLCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2018364-B1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN INC (US) 2013-08-21 EP claimed
US-7709507-B2 Therapeutic fluoroethyl ureas ALLERGAN, INC. (US) 2010-05-04 US claimed
EP-2018364-A1 THERAPEUTIC FLUOROETHYL UREAS Allergan, Inc. (US) 2009-01-28 EP claimed
WO-2007137029-A1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN, INC. (US) 2007-11-29 WO claimed
US-20070270498-A1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN, INC. 2007-11-22 US claimed
EP-2018364-B1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN INC (US) 2013-08-21 EP disclosed
EP-2018364-B1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN INC (US) 2013-08-21 EP disclosed
US-7709507-B2 Therapeutic fluoroethyl ureas ALLERGAN, INC. (US) 2010-05-04 US disclosed
US-7709507-B2 Therapeutic fluoroethyl ureas ALLERGAN, INC. (US) 2010-05-04 US disclosed
US-7709507-B2 Therapeutic fluoroethyl ureas ALLERGAN, INC. (US) 2010-05-04 US disclosed
EP-2018364-A1 THERAPEUTIC FLUOROETHYL UREAS Allergan, Inc. (US) 2009-01-28 EP disclosed
WO-2007137029-A1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN, INC. (US) 2007-11-29 WO disclosed
WO-2007137029-A1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN, INC. (US) 2007-11-29 WO disclosed
US-20070270498-A1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN, INC. 2007-11-22 US disclosed
US-20070270498-A1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN, INC. 2007-11-22 US disclosed
US-20070270498-A1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN, INC. 2007-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270498-A1 THERAPEUTIC FLUOROETHYL UREAS SLC14A1, MAPT, UTS2R SLC6A9 2068/4885SLC6A5 1553/4885OPRM1 2420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.